ESSA Pharma Inc
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada. Show More...
-
Website https://www.essapharma.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 1.68 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-09 2011-09 2012-09 2013-09 2014-09 2015-09 2016-09 2017-09 2018-09 2019-09 TTM Earnings Per Share USD -2.4 -10.6 -9.77 -3.09 -2.55 -1.24 -0.94 Dividends USD Payout Ratio % * Shares Mil 1.0 1.0 1.0 1.0 5.0 8.0 16.0 Book Value Per Share * USD 3.88 2.24 -1.5 1.89 0.03 1.93 Free Cash Flow Per Share * USD -11.5 -12.48 -12.19 -3.7 -1.39 Return on Assets % -43.41 -146.51 -146.83 -59.01 -107.56 -29.5 -71.12 Financial Leverage (Average) 1.69 1.75 1.11 1.04 Return on Equity % -480.44 -675.2 -499.79 -35.8 -83.2 Return on Invested Capital % -476.11 -639.78 -116.12 -30.89 -76.95 Interest Coverage -19.82 -109.18 -12.85 -4.59 -11.72 -16.26 -31.99 Current Ratio 1.72 2.3 0.92 1.26 4.66 9.74 27.99 Quick Ratio 1.69 1.76 0.82 1.0 4.52 9.63 27.34 Debt/Equity 0.38